China hikes prices of key drug ingredients

While increased prices will put cost pressure on the domestic industry
over the next few months, more importantly it has sparked speculation
that this could be a potential ploy by China to scupper efforts of
India's drug industry to be self-reliant, or 'Atmanirbhar'.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/china-hikes-prices-of-key-drug-ingredients/articleshow/78247294.cms

Comments

Popular posts from this blog

Clinical Database Management Professional Vacancy @ Teva

Pharma Production Executive Post Vacancy @ Intas

Biotecnika Times – Newsletter 28.02.2020 – DST Women Scientist WOS B, DBT-IOC Recruitment